')">
Market access update
The fast-paced future of cell and gene therapies
In this free report, the Medical, Consulting, Policy, Access, Value, and Evidence experts of Fishawack Health interview patients, researchers, and biopharmaceutical leaders to explore the complex landscape in the development of cell and gene therapies, and share commercial recommendations from our specialist teams.
Follow the link to learn about:
- An interview with Professor Francesco Dazzi, Medical Lead Cell Therapy, BioPharmaceuticals R&D at AstraZeneca, on the company’s novel cell therapy pipeline for chronic diseases
- Patient and market access insights on leveraging CRISPR technology for hematologic diseases
- The evolving policy and regulatory landscape for cell and gene therapies
- Trends shaping the future of personalized medicine
- Steps for communicating the complex science to a variety of stakeholders
FREE Whitepaper
The fast-paced future of cell and gene therapies
The data you submit here will be processed by us, and our partners within Fishawack Health, as outlined in our privacy policy, cookie policy, and terms and conditions.
Latest insights
